Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis | |
Zheng, JN; Pei, DS; Mao, LJ; Liu, XY; Sun, FH; Zhang, BF; Liu, YQ; Liu, JJ; Li, W; Han, D | |
刊名 | CANCER GENE THERAPY
![]() |
2010 | |
卷号 | 17期号:1页码:28-36 |
关键词 | IL-18 oncolytic adenovirus melanoma VEGF CD34 |
通讯作者 | Zheng, JN (reprint author), Xuzhou Med Coll, Affiliated Hosp, Lab Urol, 99 W Huai Hai Rd, Xuzhou 221002, Jiangsu, Peoples R China.,jnzheng@xzmc.edu.cn |
英文摘要 | It has been shown that interleukin 18 (IL-18) exerts antitumor activity. In this study, we investigated whether oncolytic adenovirus-mediated gene transfer of IL-18 could induce strong antitumor activity. A tumor-selective replicating adenovirus expressing IL-18 (ZD55-IL-18) was constructed by insertion of an IL-18 expression cassette into the ZD55 vector, which is based on deletion of the adenoviral E1B 55-kDa gene. It has been shown that ZD55-IL-18 exerted a strong cytopathic effect and significant apoptosis in tumor cells. ZD55-IL-18 significantly decreased vascular endothelial growth factor and CD34 expression in the melanoma cells. Treatment of established tumors with ZD55-IL-18 showed much stronger antitumor activity than that induced by ZD55-EGFP (enhanced green fluorescent protein) or Ad-IL-18. These data indicated that oncolytic adenovirus expressing IL-18 could exert potential antitumor activity through inhibition of angiogenesis and offer a novel approach to melanoma therapy. Cancer Gene Therapy (2010) 17, 28-36; doi: 10.1038/cgt.2009.38; published online 5 June 2009 |
学科主题 | Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity; Research & Experimental Medicine |
类目[WOS] | Biotechnology & Applied Microbiology ; Oncology ; Genetics & Heredity ; Medicine, Research & Experimental |
关键词[WOS] | ENDOTHELIAL GROWTH-FACTOR ; REPLICATION-SELECTIVE ADENOVIRUS ; RECOMBINANT HUMAN INTERLEUKIN-12 ; INTERFERON-GAMMA PRODUCTION ; RENAL-CELL CARCINOMA ; FAS-LIGAND ; IFN-GAMMA ; T-CELLS ; INTRAVENOUS-INFUSION ; SYNGENEIC MICE |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000272819100004 |
内容类型 | 期刊论文 |
版本 | 出版稿 |
源URL | [http://202.127.25.143/handle/331003/928] ![]() |
专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
推荐引用方式 GB/T 7714 | Zheng, JN,Pei, DS,Mao, LJ,et al. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis[J]. CANCER GENE THERAPY,2010,17(1):28-36. |
APA | Zheng, JN.,Pei, DS.,Mao, LJ.,Liu, XY.,Sun, FH.,...&Han, D.(2010).Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis.CANCER GENE THERAPY,17(1),28-36. |
MLA | Zheng, JN,et al."Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis".CANCER GENE THERAPY 17.1(2010):28-36. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论